PRLD logo

PRLD

Prelude Therapeutics IncorporatedNASDAQHealthcare
$3.46+0.29%ClosedMarket Cap: $192.8M

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

4

Sales

0

Buy/Sell Ratio

0.00

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Mar 19Brusky Sean P.officer: Chief Business OfficerSell0$0.00100,000
Thu Mar 19Brusky Sean P.officer: Chief Business OfficerSell275,000$0.000
Thu Feb 05Combs Andrewofficer: Chief Chemistry OfficerSell230,000$2.30230,000
Thu Feb 05Scherle Peggyofficer: Chief Scientific OfficerSell230,000$2.30230,000
Thu Feb 05Lim Bryant Davidofficer: CLO, CFO, Corp Sec.Sell275,000$2.30275,000
Thu Feb 05Vaddi Krishnadirector, officer: CEOSell837,000$2.30837,000
Fri Nov 07Sandor VictordirectorSell121,285$1.39121,285
Mon Oct 20Dorton KatinaSell0$0.000
Tue Oct 07Huang Janeofficer: President, CMOSell9,375$0.0090,272
Tue Oct 07Huang Janeofficer: President, CMOSell3,355$1.4786,917